ZEVRA THERAPEUTICS, INC. Financial Ratios
ZVRA|FY2015 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2015 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2015)
Return on Equity
-
Profit Margin
-
Net Income / Revenue
Asset Turnover
0.00
Revenue / Total Assets
Equity Multiplier
-2.30
Total Assets / Equity
Profitability
Gross Margin
-
Operating Margin
-
EBITDA
-$5.0M
EBITDA Margin
-
Liquidity
Current Ratio
6.48
Quick Ratio
6.48
Solvency
Interest Coverage
-27.56
Efficiency
Asset Turnover
0.00
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2015 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-1.6%
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.